Ga-68-PSMA PET/CT for monitoring response to Lu-177-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Alexander Heinzel*, Dima Boghos, Felix M. Mottaghy, Florian Gaertner, Markus Essler, Dirk von Mallek, Hojjat Ahmadzadehfar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1054-1062
Number of pages9
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume46
Issue number5
DOIs
Publication statusPublished - May 2019

Keywords

  • Prostate cancer
  • Lu-177-PSMA-617
  • Ga-68-PSMA PET/CT
  • Response monitoring
  • GA-68-LABELED PSMA LIGAND
  • GUIDELINE
  • INHIBITOR
  • DOSIMETRY
  • DIAGNOSIS
  • CRITERIA
  • TRENDS
  • RECIST
  • MRI

Cite this